The Valley Desk

Clinical trial reportHepatology communicationsPublished

Serum levels of hepatitis B core antibodies and hepatitis B core-related antigen at the time of nucleos(t)ide analog cessation and risk of severe flares in patients with chronic hepatitis B

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
Hepatology communications
Published
Subject terms
Humans; Hepatitis B virus; Hepatitis B, Chronic; Recurrence; Alanine Transaminase; Nucleosides; DNA, Viral; RNA, Viral; Hepatitis B Antibodies; Hepatitis B Core Antigens; Antiviral Agents; Withholding Treatment
PubMed ID
40008890
PubMed Central ID
PMC11868428
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal